Joint position of the French speaking society of pulmonology (SPLF) and tabacology (SFT) on e-cigarette use as a smoking cessation tool
This agreement on e-cigarette use as a smoking cessation tool was obtained between SPLF and SFT by progressive expert’s consensus in November 2019. • E-cigarette should not be used by non-smokers. E-cigarette use is not recommended without a smoking cessation plan. • The harmful health effects o...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Publishing
2020-10-01
|
| Series: | Tobacco Prevention and Cessation |
| Online Access: | https://www.tobaccopreventioncessation.com/Joint-position-of-the-French-speaking-society-of-pulmonology-SPLF-and-tabacology,128426,0,2.html |
| _version_ | 1797337958301302784 |
|---|---|
| author | Anne-Laurence Le Faou Anne-Marie Ruppert Bertrand Dautzenberg Nicolas Roche |
| author_facet | Anne-Laurence Le Faou Anne-Marie Ruppert Bertrand Dautzenberg Nicolas Roche |
| author_sort | Anne-Laurence Le Faou |
| collection | DOAJ |
| description | This agreement on e-cigarette use as a smoking cessation tool was obtained between SPLF and SFT by progressive expert’s consensus in November 2019.
• E-cigarette should not be used by non-smokers. E-cigarette use is not recommended without a smoking cessation plan.
• The harmful health effects of tobacco smoke on individuals and populations are significant; tobacco represents the first preventable cause of diseases and death, especially of the respiratory system.
• Smoking cessation pharmacotherapies are available and approved: nicotine replacement therapy, varenicline and bupropion (only bupropion is not reimbursed in France). These drugs must be prescribed as first-line medications before e-cigarette use.
• E-cigarette with a nicotine cartridge is a non-medicated tool of potential help for smoking cessation.
• The harmlessness of the e-cigarette, even when well used, cannot be ascertained. However, the potential toxicity of e-cigarettes, used under the conditions authorized in Europe, appears to be much lower than that of smoked tobacco.
• In the current state of knowledge, e-cigarette use is to be preferred to tobacco consumption.
• E-cigarette use aiming at smoking cessation should be of limited duration, once abstinence is achieved and the urge to smoke suppressed.
• Questions about e-cigarettes use should be part of any health professional visit.
• E-cigarettes use should be banned in closed public areas. The sale of e-cigarettes and e-liquids is prohibited for minors.
• Research on the short, medium and long-term effects of e-cigarettes must be developed.
• Regular assessment by health authorities and concerned scientific societies should be regularly performed.
These recommendations have been disseminated with a practical guidance for new e-cigarette users. |
| first_indexed | 2024-03-08T09:23:07Z |
| format | Article |
| id | doaj.art-8830c5e2bca04c2a8ded2acd8faaeefc |
| institution | Directory Open Access Journal |
| issn | 2459-3087 |
| language | English |
| last_indexed | 2024-03-08T09:23:07Z |
| publishDate | 2020-10-01 |
| publisher | European Publishing |
| record_format | Article |
| series | Tobacco Prevention and Cessation |
| spelling | doaj.art-8830c5e2bca04c2a8ded2acd8faaeefc2024-01-31T10:31:16ZengEuropean PublishingTobacco Prevention and Cessation2459-30872020-10-016Supplement10.18332/tpc/128426128426Joint position of the French speaking society of pulmonology (SPLF) and tabacology (SFT) on e-cigarette use as a smoking cessation toolAnne-Laurence Le Faou0Anne-Marie Ruppert1Bertrand Dautzenberg2Nicolas Roche3Société Francophone de Tabacologie, Paris, FranceSociété de Pneumologie de Langue Française, Paris, FranceSociété Francophone de Tabacologie, Paris, FranceSociété de Pneumologie de Langue Française, Paris, FranceThis agreement on e-cigarette use as a smoking cessation tool was obtained between SPLF and SFT by progressive expert’s consensus in November 2019. • E-cigarette should not be used by non-smokers. E-cigarette use is not recommended without a smoking cessation plan. • The harmful health effects of tobacco smoke on individuals and populations are significant; tobacco represents the first preventable cause of diseases and death, especially of the respiratory system. • Smoking cessation pharmacotherapies are available and approved: nicotine replacement therapy, varenicline and bupropion (only bupropion is not reimbursed in France). These drugs must be prescribed as first-line medications before e-cigarette use. • E-cigarette with a nicotine cartridge is a non-medicated tool of potential help for smoking cessation. • The harmlessness of the e-cigarette, even when well used, cannot be ascertained. However, the potential toxicity of e-cigarettes, used under the conditions authorized in Europe, appears to be much lower than that of smoked tobacco. • In the current state of knowledge, e-cigarette use is to be preferred to tobacco consumption. • E-cigarette use aiming at smoking cessation should be of limited duration, once abstinence is achieved and the urge to smoke suppressed. • Questions about e-cigarettes use should be part of any health professional visit. • E-cigarettes use should be banned in closed public areas. The sale of e-cigarettes and e-liquids is prohibited for minors. • Research on the short, medium and long-term effects of e-cigarettes must be developed. • Regular assessment by health authorities and concerned scientific societies should be regularly performed. These recommendations have been disseminated with a practical guidance for new e-cigarette users.https://www.tobaccopreventioncessation.com/Joint-position-of-the-French-speaking-society-of-pulmonology-SPLF-and-tabacology,128426,0,2.html |
| spellingShingle | Anne-Laurence Le Faou Anne-Marie Ruppert Bertrand Dautzenberg Nicolas Roche Joint position of the French speaking society of pulmonology (SPLF) and tabacology (SFT) on e-cigarette use as a smoking cessation tool Tobacco Prevention and Cessation |
| title | Joint position of the French speaking society of pulmonology (SPLF) and tabacology (SFT) on e-cigarette use as a smoking cessation tool |
| title_full | Joint position of the French speaking society of pulmonology (SPLF) and tabacology (SFT) on e-cigarette use as a smoking cessation tool |
| title_fullStr | Joint position of the French speaking society of pulmonology (SPLF) and tabacology (SFT) on e-cigarette use as a smoking cessation tool |
| title_full_unstemmed | Joint position of the French speaking society of pulmonology (SPLF) and tabacology (SFT) on e-cigarette use as a smoking cessation tool |
| title_short | Joint position of the French speaking society of pulmonology (SPLF) and tabacology (SFT) on e-cigarette use as a smoking cessation tool |
| title_sort | joint position of the french speaking society of pulmonology splf and tabacology sft on e cigarette use as a smoking cessation tool |
| url | https://www.tobaccopreventioncessation.com/Joint-position-of-the-French-speaking-society-of-pulmonology-SPLF-and-tabacology,128426,0,2.html |
| work_keys_str_mv | AT annelaurencelefaou jointpositionofthefrenchspeakingsocietyofpulmonologysplfandtabacologysftonecigaretteuseasasmokingcessationtool AT annemarieruppert jointpositionofthefrenchspeakingsocietyofpulmonologysplfandtabacologysftonecigaretteuseasasmokingcessationtool AT bertranddautzenberg jointpositionofthefrenchspeakingsocietyofpulmonologysplfandtabacologysftonecigaretteuseasasmokingcessationtool AT nicolasroche jointpositionofthefrenchspeakingsocietyofpulmonologysplfandtabacologysftonecigaretteuseasasmokingcessationtool |